0001203311-13-000096.txt : 20131209
0001203311-13-000096.hdr.sgml : 20131209
20131209183804
ACCESSION NUMBER: 0001203311-13-000096
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131205
FILED AS OF DATE: 20131209
DATE AS OF CHANGE: 20131209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIEGALL CLAY B
CENTRAL INDEX KEY: 0001167496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 131266648
MAIL ADDRESS:
STREET 1: 21823 30TH DR SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-12-05
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001167496
SIEGALL CLAY B
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2013-12-05
4
M
0
18996.0
5.92
A
1043554
D
Incentive Stock Option (right to buy)
5.92
2013-12-05
4
M
0
18996.0
0.0
D
2006-01-31
2015-01-31
Common Stock
18996
0
D
Amount of securities beneficially owned following reported transactions includes 189,250 Restricted Stock Units subject to vesting.
25% of the shares vested on 1/31/06. The remainder vested monthly thereafter until all shares were vested on 1/31/09.
Clay B. Siegall
2013-12-09